Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2.
Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2.
复制标题
肠道菌群不平衡通过调节色氨酸代谢和上调SREBP2促进肝癌的发生
DOI:
10.1073/pnas.2203894119
复制
发表时间:
2022-12-27
影响因子:
11.1
通讯作者:
中科院分区:
文献类型:
--
作者:
Primary liver cancer is currently the sixth most common cancer and fourth leading cause of cancer-related death globally. The limited therapeutic options and poor prognosis of patients with primary liver cancer highlight the significance of developing cancer prevention strategies. Our findings identified a mechanism of gut flora disequilibrium-promoted liver cancer initiation via a tryptophan metabolism-balanced AhR-SREBP2 axis between the gut and liver. Our results might contribute to developing strategies for liver cancer prevention through gut flora manipulation. The gut microbiota and liver cancer have a complex interaction. However, the role of gut microbiome in liver tumor initiation remains unknown. Herein, liver cancer was induced using hydrodynamic transfection of oncogenes to explore liver tumorigenesis in mice. Gut microbiota depletion promoted liver tumorigenesis but not progression. Elevated sterol regulatory element-binding protein 2 (SREBP2) was observed in mice with gut flora disequilibrium. Pharmacological inhibition of SREBP2 or Srebf2 RNA interference attenuated mouse liver cancer initiation under gut flora disequilibrium. Furthermore, gut microbiota depletion impaired gut tryptophan metabolism to activate aryl hydrocarbon receptor (AhR). AhR agonist Ficz inhibited SREBP2 posttranslationally and reversed the tumorigenesis in mice. And, AhR knockout mice recapitulated the accelerated liver tumorigenesis. Supplementation with Lactobacillus reuteri, which produces tryptophan metabolites, inhibited SREBP2 expression and tumorigenesis in mice with gut flora disequilibrium. Thus, gut flora disequilibrium promotes liver cancer initiation by modulating tryptophan metabolism and up-regulating SREBP2.
登录
查看更多内容
影响因子:
32.4
作者:
Hezaveh K;Shinde RS;Klötgen A;Halaby MJ;Lamorte S;Ciudad MT;Quevedo R;Neufeld L;Liu ZQ;Jin R;Grünwald BT;Foerster EG;Chaharlangi D;Guo M;Makhijani P;Zhang X;Pugh TJ;Pinto DM;Co IL;McGuigan AP;Jang GH;Khokha R;Ohashi PS;O'Kane GM;Gallinger S;Navarre WW;Maughan H;Philpott DJ;Brooks DG;McGaha TL
通讯作者:
McGaha TL
影响因子:
5.2
作者:
Ni, Jiajia;Huang, Rong;Gao, Yi
通讯作者:
Gao, Yi
影响因子:
64.5
作者:
Moon, Sung-Hwan;Huang, Chun-Hao;Prives, Carol
通讯作者:
Prives, Carol
影响因子:
5.6
作者:
Chen YH;Wu WK;Wu MS
通讯作者:
Wu MS
影响因子:
50.3
作者:
Dapito DH;Mencin A;Gwak GY;Pradere JP;Jang MK;Mederacke I;Caviglia JM;Khiabanian H;Adeyemi A;Bataller R;Lefkowitch JH;Bower M;Friedman R;Sartor RB;Rabadan R;Schwabe RF
通讯作者:
Schwabe RF